Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder
- PMID: 15101491
- DOI: 10.1016/s1098-3597(03)90095-0
Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder
Abstract
Although gastroesophageal reflux disease (GERD) is frequently referred to as a continuous spectrum, it is more useful to consider GERD as 2 discrete entities with several subsets that differ in pathophysiology, clinical presentation, natural history, and therapy. One entity is classic severe acid reflux with erosive esophagitis and its complications. Barrett's esophagus is an important subset of this group, with markedly increased acid exposure and an increased risk of adenocarcinoma. The second entity is nonerosive reflux disease (NERD) with minimal or no esophagitis. Patients with NERD do not develop local mucosa complications, like stricture or Barrett's esophagus, but their symptom severity can equal that of erosive esophagitis. Acid is involved in the symptoms of many but not all NERD patients. This acid dependence is evident either as an increase in esophageal acid reflux or a hypersensitivity to acid, and both generally respond well to proton pump inhibitor (PPI) therapy. NERD patients who are not acid-dependent have what is called functional heartburn; GERD-like symptoms are present, but there is no obvious involvement of refluxed acid. An important subset of GERD is refractory GERD, which consists of patients who fail aggressive PPI therapy. Parallel findings with other refractory syndromes can be anticipated; however, there are indications that psychosocial factors play a major role in refractory GERD, and these patients may benefit more from an integrated biopsychosocial approach. Diagnosis of GERD is usually made on clinical grounds, often supplemented by a therapeutic trial with antisecretory agents. Endoscopy is reserved for patients with alarm symptoms, such as dysphagia, anemia, or weight loss, or to detect Barrett's esophagus. Endoscopy is not useful to exclude the diagnosis of GERD because it will be negative in 70% of cases in primary care. Ambulatory 24-hour esophageal pH monitoring is necessary only when the diagnosis is in doubt, the patient fails medical management, or surgery is contemplated.
Similar articles
-
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2. Dis Esophagus. 2013. PMID: 22862422
-
Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.Dig Dis Sci. 2011 Oct;56(10):2871-8. doi: 10.1007/s10620-011-1708-9. Epub 2011 Apr 22. Dig Dis Sci. 2011. PMID: 21512760
-
AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.Clin Gastroenterol Hepatol. 2022 May;20(5):984-994.e1. doi: 10.1016/j.cgh.2022.01.025. Epub 2022 Feb 2. Clin Gastroenterol Hepatol. 2022. PMID: 35123084 Free PMC article. Review.
-
Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.Dis Esophagus. 2023 Jul 3;36(7):doac102. doi: 10.1093/dote/doac102. Dis Esophagus. 2023. PMID: 36567531
-
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4. Arq Gastroenterol. 2018. PMID: 30304291 Review.
Cited by
-
The frequency of histological features mimicking reflux esophagitis: a study in non-human primates.In Vivo. 2008 Nov-Dec;22(6):721-4. In Vivo. 2008. PMID: 19180997 Free PMC article.
-
The influence of psychological factors on the outcomes of laparoscopic Nissen fundoplication.Ann Surg Innov Res. 2007 Feb 20;1:2. doi: 10.1186/1750-1164-1-2. Ann Surg Innov Res. 2007. PMID: 17411450 Free PMC article.
-
The Risk of Acute Myocardial Infarction in Patients With Gastroesophageal Reflux Disease.J Neurogastroenterol Motil. 2020 Sep 30;26(4):471-476. doi: 10.5056/jnm19192. J Neurogastroenterol Motil. 2020. PMID: 32989184 Free PMC article.
-
Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease.Caspian J Intern Med. 2022 Winter;13(1):107-112. doi: 10.22088/cjim.13.1.107. Caspian J Intern Med. 2022. PMID: 35178215 Free PMC article.
-
Regurgitation in healthy and non healthy infants.Ital J Pediatr. 2009 Dec 9;35(1):39. doi: 10.1186/1824-7288-35-39. Ital J Pediatr. 2009. PMID: 20003194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical